CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

DUR-928Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug2122 Placebo Wiki 0.05

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D014029 Tobacco Use Disorder NIH 0.58
D002318 Cardiovascular Diseases NIH 0.19

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0001626 Abnormality of the cardiovascular system HPO 0.19

There is one clinical trial.

Clinical Trials

1 A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Safety and Efficacy of DUR-928 in Subjects Infected With SARS-CoV-2 With Acute Liver or Kidney Injury

Evaluate safety and efficacy of DUR-928 in treatment of acute organ failure in subjects infected with SARS-CoV-2

NCT04447404 SARS-CoV 2 Drug: DUR-928 Drug: Placebo

Primary Outcomes

Description: Free of mechanical ventilation, free of renal replacement therapy and free of acute liver failure

Measure: Composite endpoint of alive and free of organ failure

Time: Day 28

Measure: Occurrence of serious adverse events following treatment

Time: Day 1 to Day 60

Secondary Outcomes

Measure: Alive at days 28 and 60

Time: Days 28 and 60

Measure: Alive and out of ICU

Time: Day 28

Measure: Alive and out of hospital

Time: Day 28 and Day 60

No related HPO nodes (Using clinical trials)